LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 267 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $65,000 | -4.4% | 900 | +50.0% | 0.03% | +65.0% |
| Q2 2019 | $68,000 | +25.9% | 600 | +50.0% | 0.02% | +17.6% |
| Q4 2018 | $54,000 | -82.1% | 400 | -63.6% | 0.02% | -70.2% |
| Q3 2018 | $301,000 | -27.6% | 1,100 | -45.0% | 0.06% | -40.0% |
| Q2 2018 | $416,000 | -4.8% | 2,000 | -25.9% | 0.10% | -12.0% |
| Q1 2018 | $437,000 | +355.2% | 2,700 | +285.7% | 0.11% | +390.9% |
| Q4 2017 | $96,000 | -78.6% | 700 | -78.8% | 0.02% | -77.8% |
| Q3 2017 | $449,000 | -15.9% | 3,300 | -25.0% | 0.10% | +26.9% |
| Q2 2017 | $534,000 | -23.6% | 4,400 | -33.3% | 0.08% | -2.5% |
| Q1 2017 | $699,000 | -3.1% | 6,600 | -7.0% | 0.08% | -12.1% |
| Q4 2016 | $721,000 | +33.3% | 7,100 | +34.0% | 0.09% | +30.0% |
| Q3 2016 | $541,000 | +37.3% | 5,300 | +60.6% | 0.07% | +27.3% |
| Q2 2016 | $394,000 | – | 3,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |